Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Xia, Qiang  [Clear All Filters]
2024
Zhang K, Wan P, Wang L, Wang Z, Tan F, Li J, Ma X, Cen J, Yuan X, Liu Y, et al. Efficient expansion and CRISPR-Cas9-mediated gene correction of patient-derived hepatocytes for treatment of inherited liver diseases. Cell Stem Cell. 2024.
Pan Y, Zheng Z, Zhang X, Liu S, Zhuansun S, Gong S, Li S, Wang H, Chen Y, Yang T, et al. Hybrid Bioactive Hydrogel Promotes Liver Regeneration Through the Activation of Kupffer Cells and ECM Remodeling After Partial Hepatectomy. Adv Healthc Mater. 2024:e2303828.
2023
Zhang K, Wu N, Cen J, Li J, Wang Z, Xia Q, Hui L. Ex vivo factor VIII-modified proliferating human hepatocytes therapy for haemophilia A. Cell Prolif. 2023:e13467.
Che Y, Chen G, Guo Q, Duan Y, Feng H, Xia Q. Gut microbial metabolite butyrate improves anticancer therapy by regulating intracellular calcium homeostasis. Hepatology. 2023.
Sun X-C, Kong D-F, Zhao J, Faber KNico, Xia Q, He K. Liver organoids: established tools for disease modeling and drug development. Hepatol Commun. 2023;7(4).
Zhao Z, Qing Y, Dong L, Han L, Wu D, Li Y, Li W, Xue J, Zhou K, Sun M, et al. QKI shuttles internal mG-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023.
2022
Yu Y, Zhang Q, Wu N, Xia L, Cao J, Xia Q, Zhao J, Zhang J, Hang H. HNF4α overexpression enhances the therapeutic potential of umbilical cord mesenchymal stem/stromal cells in mice with acute liver failure. FEBS Lett. 2022.
2020
Zeng X, Zhou J, Xiong Z, Sun H, Yang W, Mok MTS, Wang J, Li J, Liu M, Tang W, et al. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis. Cell Mol Immunol. 2020.
2016
Yue S, Zhu J, Zhang M, Li C, Zhou X, Zhou M, Ke M, Busuttil RW, Ying Q, Kupiec-Weglinski JW, et al. The Myeloid HSF1-Β-Catenin Axis Regulates NLRP3 Inflammasome Activation in Mouse Liver Ischemia/Reperfusion Injury. Hepatology. 2016.
Wu N, Zhang Y-L, Wang H-T, Li D-W, Dai H-J, Zhang Q-Q, Zhang J, Ma Y, Xia Q, Bian J-M, et al. Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation. Cancer Biol Ther. 2016.
2014
Hang H, Yu Y, Wu N, Huang Q, Xia Q, Bian J. Induction of Highly Functional Hepatocytes from Human Umbilical Cord Mesenchymal Stem Cells by HNF4α Transduction. PLoS One. 2014;9(8):e104133.